SciClone Pharmaceuticals COO Dr. Alfred Rudolph has resigned. CEO Friedhelm Blobel will temporarily take over Rudolph's duties while the company searches for his successor.
Bashir Jaffer has been appointed to serve as the COO of Chemokine Therapeutics.
Mark L. Perry, Aerovance's current chairman of the board, has been elected to the position of executive chairman. Douglas E. Williams Ph.D. has been appointed a director.
Aastrom Biosciences has announced that Stephen G. Sudovar, CEO of SGS Associates and former President of Roche Laboratories, has been elected chairman of the company's board of directors.
Dr. John Villiger has been appointed as Pharmaxis' board director.
Starpharma announced the appointment of Mr. Richard Hazleton, the former chairman of the US-based global corporation Dow Corning, as a non-executive director.
Harry J. D'Andrea as been elected to Martek Biosciences' board of directors.
Celtic Pharma Development Services Bermuda has appointed Bob Milsted as managing director and head of European development and Solomon Babani as director of contracts and vendor management.